Press Releases
Total Revenue of $1,096 million GAAP Diluted EPS $0.50, Non-GAAP Diluted EPS1 $0.79
PLANO, Texas--(BUSINESS WIRE)-- Upbound Group, Inc. (the "Company" or "Upbound") (NASDAQ: UPBD) today announced results for the quarter ended March 31, 2024. The earnings release, financial tables and related materials can be found on the Company's investor relations website at https://investor.upbound.com.
Today at 9 a.m. ET, Mitch Fadel, Chief Executive Officer, and Fahmi... (continue reading...)
The first-in-kind energy storage deployment will lower utility costs by approximately $200 million, while improving resilience and sustainability at community and state levels
LUDLOW, Mass.--(BUSINESS WIRE)-- The Massachusetts Municipal Wholesale Electric Company (MMWEC), the Commonwealth’s designated joint action agency for municipal utilities, and Lightshift Energy, a leading energy storage project developer, owner and operator, today announced a... (continue reading...)
RADNOR, Pa.--(BUSINESS WIRE)-- Lincoln Financial Group (NYSE: LNC) today reported financial results for the first quarter ended March 31, 2024.
- Net income available to common stockholders was $1.2 billion, or $6.93 per diluted share.
- Adjusted operating income available to common stockholders was $71 million, or $0.41 per diluted share.
- Adjusted operating income available to stockholders was unfavorably impacted by significant items totaling $164 million, or... (continue reading...)
Multiple preclinical and clinical abstracts accepted for presentation at 2024 ASCO Annual Meeting and AACR Annual Meeting underscore breadth of Bicycle® platform technology and pipeline
Continued progress across research and development (R&D) pipeline, with numerous clinical data readouts and updates expected in 2H 2024
Mike Hannay, D.Sc., FRPharmS, promoted to Chief Product and Supply Chain Officer
Cash and cash equivalents of $457.0 million as of March 31,... (continue reading...)
Andy Youé joins Wavelo to scale sales organization, accelerating the mission to help operators globally increase revenue and decrease costs
TORONTO, May 2, 2024 /PRNewswire/ - Today Wavelo—a modern software company providing flexible solutions to communication service providers (CSPs) globally—announced the appointment of Andy Youé as Vice President of Sales.
More Press Releases
View Older Stories-
Quell Therapeutics Highlights Clinical Potential of QEL-001 and its Multi-Modular Treg Cell Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-
PreludeDx Welcomes Dr. Pat Whitworth as Chief Medical Officer to Drive Expansion of Precision Diagnostics
-
Franklin County School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students
-
Magnolia Oil & Gas Announces Quarterly Dividend
-
Moody's Corporation Reports Results for First Quarter 2024
-
Axogen, Inc Reports First Quarter 2024 Financial Results
-
Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
-
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
-
BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline
-
Origin Materials Partners with IMDvista on World’s First PET Cap and Closure Manufacturing System
-
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
-
CertaSite and Asher's Racing Channel announce winning partnership
-
Colliers Reports First Quarter Results
-
Athira Pharma to Participate in Upcoming May Conferences
-
Plug Continues to Expand Cryogenic Sales with Multiple Customer Agreements and International Expansion
-
Arqit and SoftIron Partner to sell more secure data center deployments
-
PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Target for Green Cement Additive Product
-
Lantheus Reports First Quarter 2024 Financial Results
-
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
-
Malibu Boats, Inc. Announces Third Quarter Fiscal 2024 Results
-
Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage
-
Smith Douglas Homes Recognized Among the Top Customer Service Leaders in the Residential Construction Industry
-
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
-
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
-
Comic Book Fans Rally for Children International:
-
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
-
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
-
Alta Equipment Group Announces Common Stock Dividend
-
Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
-
Delphia Therapeutics Launches to Pioneer a New Field of Cancer Medicines: Activation Lethality
-
Alpha Transform Holdings Announces Strategic Investments in AI
-
insightsoftware Recognized as DACH Region Market Leader for Sixth Consecutive Year in BARC Score Financial Performance Management Report
-
Arvinas to Present at Upcoming Investor Conferences
-
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
-
Flashtalking by Mediaocean named Leader in 2024 SPARK Matrix for AdTech by Quadrant Knowledge Solutions
-
Masterworks Surpasses $1 Billion In Capital Raised
-
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024
-
FactSet Increases Dividend
-
Quell Therapeutics Highlights Clinical Potential of QEL-001 and its Multi-Modular Treg Cell Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-
Fenix Outdoor: Q1 report Fenix Outdoor International AG
-
Pneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Drug for Viral Respiratory Tract Infections, at ATS 2024
-
Xylem Reports First Quarter 2024 Results and Raises Full-Year Guidance
-
QUANTA SERVICES REPORTS FIRST QUARTER 2024 RESULTS
-
AMETEK Announces Record First Quarter Results and Raises 2024 Guidance
-
Church & Dwight Reports Q1 2024 Results
-
U.K.-Based Footwear Brand FitFlop Selects Ryder as U.S. Supply Chain and Logistics Provider
-
Dollar General Corporation Announces Webcast of its First Quarter 2024 Earnings Conference Call
-
YieldMax™ Launches Short TSLA Option Income Strategy ETF CRSH
-
Bulletin from Physitrack PLC’s (publ) Annual General Meeting
-
Exelon Reports First Quarter 2024 Results